ArticleOncoimmunology
Ibrutinib enhances IL-17 response by modulating the function of bone marrow derived dendritic cells.
Gayathri Natarajan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
trialcites it
ArticleOncoimmunology
Gayathri Natarajan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.